BARBARA HARRIS: Open Payments
NPI 1750848271 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$756 in 28 payments from 5 companies in 2025. Trend: 2023 $105 · 2024 $417 · 2025 $756
Food & beverage: $661Education: $94
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $302 |
| Janssen Biotech, Inc. | 5 | $301 |
| ABBVIE INC. | 1 | $123 |
| GENZYME CORPORATION | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $10 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, EOHILIA, DUPIXENT.
Industry payments across IL — which companies pay providers there.
